Pancreatic Stereotactic Body Radiation Therapy (SBRT) in the Era of Multi-Agent Chemotherapy for Locally Advanced and Borderline Resectable Pancreatic Cancer: A Prospective Single Institution Study
Few studies have examined the role of stereotactic body radiation (SBRT) after multiagent chemotherapy (ChT) in pancreatic ductal adenocarcinoma (PDAC). This was a prospective study of SBRT after ChT for PDAC.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Susannah Ellsworth, Michael House, Bert O'Neil, Safi Shahda, Attila Nakeeb, Amy Miller, Sarah Brennan, Amikar Sehdev Source Type: research
More News: Adenocarcinoma | Biology | Cancer | Cancer & Oncology | Chemotherapy | Pancreas | Pancreatic Cancer | Physics | Radiation Therapy | Radiology | Study